Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location or be switched to your location?
Analysis of FAK (pS910) in human epithelioid carcinoma. Hela S3 cells (ATCC CCL 2.2) were either stimulated with Nocodazole at 37°C for 16 hours (shaded histogram) or unstimulated (open histogram). The cells were fixed (BD Cytofix™ buffer, Cat. No. 554655) for 10 minutes at 37°C, then permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for at least 30 minutes, then stained with Alexa Fluor® 647 Mouse anti-FAK (pS910 Cat. No. 558545). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Analysis of FAK (pS910) in human epithelioid carcinoma. Hela S3 cells (ATCC CCL 2.2) were either stimulated with Nocodazole at 37°C for 16 hours (shaded histogram) or unstimulated (open histogram). The cells were fixed (BD Cytofix™ buffer, Cat. No. 554655) for 10 minutes at 37°C, then permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for at least 30 minutes, then stained with Alexa Fluor® 647 Mouse anti-FAK (pS910 Cat. No. 558545). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Analysis of FAK (pS910) in human epithelioid carcinoma. Hela S3 cells (ATCC CCL 2.2) were either stimulated with Nocodazole at 37°C for 16 hours (shaded histogram) or unstimulated (open histogram). The cells were fixed (BD Cytofix™ buffer, Cat. No. 554655) for 10 minutes at 37°C, then permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for at least 30 minutes, then stained with Alexa Fluor® 647 Mouse anti-FAK (pS910 Cat. No. 558545). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Analysis of FAK (pS910) in human epithelioid carcinoma. Hela S3 cells (ATCC CCL 2.2) were either stimulated with Nocodazole at 37°C for 16 hours (shaded histogram) or unstimulated (open histogram). The cells were fixed (BD Cytofix™ buffer, Cat. No. 554655) for 10 minutes at 37°C, then permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for at least 30 minutes, then stained with Alexa Fluor® 647 Mouse anti-FAK (pS910 Cat. No. 558545). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Analysis of FAK (pS910) in human epithelioid carcinoma. Hela S3 cells (ATCC CCL 2.2) were either stimulated with Nocodazole at 37°C for 16 hours (shaded histogram) or unstimulated (open histogram). The cells were fixed (BD Cytofix™ buffer, Cat. No. 554655) for 10 minutes at 37°C, then permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for at least 30 minutes, then stained with Alexa Fluor® 647 Mouse anti-FAK (pS910 Cat. No. 558545). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Analysis of FAK (pS910) in human epithelioid carcinoma. Hela S3 cells (ATCC CCL 2.2) were either stimulated with Nocodazole at 37°C for 16 hours (shaded histogram) or unstimulated (open histogram). The cells were fixed (BD Cytofix™ buffer, Cat. No. 554655) for 10 minutes at 37°C, then permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for at least 30 minutes, then stained with Alexa Fluor® 647 Mouse anti-FAK (pS910 Cat. No. 558545). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Becton, Dickinson and Company의 명시적인 서면 승인 없이는 사용 하실 수 없습니다.
Focal Adhesion Kinase (FAK) is a cytoplasmic tyrosine kinase that associates with integrins in focal adhesions. Its cellular localization is directed by a 125-amino acid sequence at the C terminus called the "Focal Adhesion Targeting" (FAT) domain, and the phosphorylation state of serine 910 (S910) in the FAT domain may regulate the assembly of focal adhesions. Furthermore, the binding of extracellular matrix ligands to integrins triggers tyrosine phosphorylations near FAK's kinase domain that increase its kinase activity, and additional tyrosine phosphorylations near proline-rich motifs create binding sites for the SH2 domains of various adaptor proteins. FAK's ability to bind numerous structural and signaling proteins via a variety of interactions regulates FAK's targeting to focal adhesions, modulates its kinase activity, and initiates intracellular signaling cascades. Thus, studies suggest that FAK may integrate cellular events controlling cell motility, growth, and invasiveness.
The K73-480 monoclonal antibody recognizes the phosphorylated S910 of human FAK. The orthologous phosphorylation sites in mouse and rat FAK are S948 and S913, respectively.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.